Abstract
Aim. The signalling pathway consisting of receptor activator of NF-kB (RANK), its ligand (RANKL), and osteoprotegerin (OPG) has been recently thought to be an important mediator between inflammation and bone loss. We aimed at evaluating the activation state of RANKL/OPG system and its relationship with low bone mineral density (BMD) in children with IBD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
